Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein lin-52 homolog (LIN52) is a small protein subunit of the MuvB core complex, which is central to the assembly and function of cell cycle-regulatory transcriptional complexes: DREAM (quiescent state gene repression) and MMB/FOXM1-MuvB (mitotic gene activation)[1][2][3][4][5]. LIN52 is responsible for recruiting pocket proteins p107/p130 and B-MYB, controlling dynamic transitions between cell cycle phases. Phosphorylation by DYRK1A at Ser28 on LIN52 triggers DREAM complex formation by enabling specific binding to p107/p130, thus repressing cell cycle genes during cell quiescence[1][3]. When not phosphorylated, LIN52 helps form the MMB complex with B-MYB that activates mitotic gene transcription[1][2]. LIN52 itself acts only within these multi-protein complexes, and there are no known drugs targeting it directly. Dysfunction of the MuvB/DREAM complex, including LIN52, is implicated in cancer through loss of cell cycle checkpoint control and abnormal cell proliferation[1][3][5].
Not applicable directly; no drugs act on LIN52 itself. Indirect mechanism: Kinase inhibitors (e.g., DYRK1A inhibitors) may modulate DREAM complex assembly by affecting LIN52 phosphorylation[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein lin-52 homolog (LIN52).